Simple, sensitive and rapid LC–MS/MS method for the quantitation of cerivastatin in human plasma — application to pharmacokinetic studies

This publication has 28 references indexed in Scilit:

• Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells
  Cellular Signalling, 2002
• Cerivastatin enhances the cytotoxicity of 5‐fluorouracil on chemosensitive and resistant colorectal cancer cell lines
  FEBS Letters, 2002
• Statins and their potential for osteoporosis
  Bone, 2001
• Pleiotropic Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2001
• Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells
  Leukemia, 2001
• Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study
  Carcinogenesis: Integrative Cancer Research, 2001
• Simvastatin Has Anti-Inflammatory and Antiatherosclerotic Activities Independent of Plasma Cholesterol Lowering
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2001
• Cerivastatin
  Drugs, 2000
• Non-lipid-related effects of statins
  Annals of Medicine, 2000
• Inhibition of the 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Pathway Induces p53-independent Transcriptional Regulation of p21 in Human Prostate Carcinoma Cells
  Published by Elsevier ,1998